Modified paracetamol 665mg or less is being upscheduled to S3 because pharmacist oversight is needed to reduce the risk of harm.
Modified paracetamol upscheduled to prevent harm.
This is one of the interim decisions from the federal Department of Health’s scheduling delegates’ March meeting.
The delegate found the “complex and unpredictable” pharmacokinetic profile of MR paracetamol following an overdose posed an unacceptable risk to the population.
“The view is there is the potential for harm if it is used inappropriately, and … upscheduling MR paracetamol products to schedule 3 would allow for additional pharmacist oversight while retaining public access.”
This has been reproduced from the Pharmacy News from AusDoc.Plus – Click here for more information>>